Walder Wyss advised Alentis Therapeutics on the deal. Honigman advised Catalio Capital Management. Alentis Therapeutics raised $181.4 million in Series D financing, supported by a syndicate...
You must be a Standard 1 Year member to access this content.
Covington & Burling LLP represented Catalio Capital Management, LP in the deal. TapestryHealth announced $25 million credit investment from Catalio Capital Management (“Catalio”). The term loan is an...
You must be a Standard 1 Year member to access this content.
Goodwin advised DNA Script on the deal. Dentons advised Bpifrance Large Venture. August Debouzy advised Coatue Management, Catalio Capital Management and Fidelity Management and Research. DNA...
You must be a Standard 1 Year member to access this content.
Noerr advised Catalio Capital Management LP on the deal. ATAI Life Sciences, a clinical-stage biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications, announced...
You must be a Standard 1 Year member to access this content.
